Igm Biosciences Stock Price on September 4, 2024
| IGMS Stock | USD 9.46 0.06 0.64% |
Below is the normalized historical share price chart for IGM Biosciences extending back to September 18, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of IGM Biosciences stands at 9.46, as last reported on the 26th of November, with the highest price reaching 9.93 and the lowest price hitting 9.05 during the day.
If you're considering investing in IGM Stock, it is important to understand the factors that can impact its price. Currently, IGM Biosciences is slightly risky. IGM Biosciences holds Efficiency (Sharpe) Ratio of 0.0226, which attests that the entity had a 0.0226% return per unit of volatility over the last 3 months. We have found twenty-seven technical indicators for IGM Biosciences, which you can use to evaluate the volatility of the firm. Please check out IGM Biosciences' market risk adjusted performance of 0.048, and Risk Adjusted Performance of 0.0186 to validate if the risk estimate we provide is consistent with the expected return of 0.17%.
At this time, IGM Biosciences' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 444.6 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 26.4 M in 2024. . At this time, IGM Biosciences' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.21 in 2024, whereas Price Earnings Ratio is likely to drop (1.85) in 2024. IGM Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of September 2019 | 200 Day MA 11.0429 | 50 Day MA 14.6799 | Beta 0.192 |
IGM |
Sharpe Ratio = 0.0226
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IGMS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.39 actual daily | 65 65% of assets are less volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average IGM Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IGM Biosciences by adding it to a well-diversified portfolio.
Price Book 6.6961 | Enterprise Value Ebitda (1.99) | Price Sales 191.557 | Shares Float 1.5 B | Wall Street Target Price 19.6 |
Related Headline
Scpharmaceuticals Headline on 4th of September 2024
scPharmaceuticals to Present at the H.C. Wainwright 26th Ann... by finance.yahoo.com
BURLINGTON, Mass., Sept. 04, 2024 -- scPharmaceuticals Inc. , a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President Chief Executive Officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11 at 1000AM ET. Mr. Tucker will als
IGM Biosciences Valuation on September 4, 2024
It is possible to determine the worth of IGM Biosciences on a given historical date. On September 4, 2024 IGM was worth 9.63 at the beginning of the trading date compared to the closed value of 10.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of IGM Biosciences stock. Still, in general, we apply an absolute valuation method to find IGM Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of IGM Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against IGM Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 10.14 | 10.88 | 9.83 | 9.86 | 165,761 | |
09/04/2024 | 9.63 | 10.95 | 9.62 | 10.40 | 205,981 |
| 10.24 | 10.34 | 9.67 | 10.25 | 196,365 |
| Backtest IGM Biosciences | | | IGM Biosciences History | | | IGM Biosciences Valuation | Previous | Next |
IGM Biosciences Trading Date Momentum on September 4, 2024
| On September 05 2024 IGM Biosciences was traded for 10.25 at the closing time. The top price for the day was 10.34 and the lowest listed price was 9.67 . The trading volume for the day was 196.4 K. The trading history from September 5, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.44% . The trading delta at closing time against the current closing price is 19.23% . |
IGM Biosciences Fundamentals Correlations and Trends
By evaluating IGM Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among IGM Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. IGM financial account trend analysis is a perfect complement when working with valuation or volatility modules.About IGM Biosciences Stock history
IGM Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IGM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in IGM Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing IGM Biosciences stock prices may prove useful in developing a viable investing in IGM Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 52.3 M | 26.4 M | |
| Net Loss | -199 M | -189 M |
IGM Biosciences Quarterly Net Working Capital |
|
IGM Biosciences Stock Technical Analysis
IGM Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
IGM Biosciences Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
IGM Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
IGM Biosciences November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how IGM Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IGM Biosciences shares will generate the highest return on investment. By undertsting and applying IGM Biosciences stock market strength indicators, traders can identify IGM Biosciences entry and exit signals to maximize returns
IGM Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for IGM Biosciences' price direction in advance. Along with the technical and fundamental analysis of IGM Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of IGM to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0186 | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (1.05) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.038 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.